Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News GeneDx Holdings Corporation WGS

Alternate Symbol(s):  WGSWW

Financial Services Healthcare Diagnostics & Research
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and... see more

Recent & Breaking News (NDAQ:WGS)

GeneDx to Participate in Upcoming Investor Conferences

Business Wire 8 days ago

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Business Wire 10 days ago

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Business Wire February 11, 2026

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Business Wire February 3, 2026

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire January 15, 2026

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Business Wire January 12, 2026

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

Business Wire January 8, 2026

GeneDx Announces GenomeDx Prenatal(TM), Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Business Wire January 7, 2026

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Business Wire January 6, 2026

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Business Wire January 5, 2026

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Business Wire December 30, 2025

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Business Wire December 15, 2025

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

PR Newswire November 30, 2025

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Business Wire November 6, 2025

GeneDx to Participate in Upcoming Investor Conferences

Business Wire November 4, 2025

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Business Wire October 28, 2025

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

PR Newswire October 27, 2025

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire October 24, 2025

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Business Wire October 22, 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx(TM) and GenomeDx(TM) Testing

Business Wire October 20, 2025

Podcasts